Immune Induction Strategies to Improve Response to Immune Checkpoint Blockade in Triple Negative Breast Cancer (TNBC) Patients
Clinical trial NCT04159818 · RECRUITING
Trial details
- NCT number
- NCT04159818
- Sponsor
- The Netherlands Cancer Institute
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-21
- Primary completion
- 2022-12-15
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.